Levi D Pederson (Levi Pederson, L D Pederson)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Newly Diagnosed

Positron Emission Tomography

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood cancer journal

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah C Rutherford, Jun Yin, Levi D Pederson, Kristie A Blum, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara Rosenbaum, Bruce D Cheson, Nancy L Bartlett, Sumithra J Mandrekar, John P Leonard
Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma. Blood advances 8 (6) (2024)
Sarah C Rutherford, Jun Yin, Levi D Pederson, Kristie A Blum, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara Rosenbaum, Bruce D Cheson, Nancy L Bartlett, Sumithra J Mandrekar, John P Leonard
Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma. Blood advances 8 (6) (2024)
Sarah C Rutherford, Jun Yin, Levi D Pederson, Kristie A Blum, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara A Rosenbaum, Bruce David Cheson, Nancy L Bartlett, Sumithra J Mandrekar, John P Leonard
Impact of Imaging Frequency on Progression Free Survival in Alliance Trials Enrolling Patients with Follicular Lymphoma. Blood advances (2024)
Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven R Alberts, Aimery deGramont, Jeffrey A Meyerhardt, Thomas J George, Hans-Joachim E Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A Sinicrope, Eiji Oki, Anthony Frank Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M Goldberg, Gilles Manceau, Demetris Papamichael
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven R Alberts, Aimery deGramont, Jeffrey A Meyerhardt, Thomas J George, Hans-Joachim E Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A Sinicrope, Eiji Oki, Anthony Frank Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M Goldberg, Gilles Manceau, Demetris Papamichael
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sarah C Rutherford, Jun Yin, Levi D Pederson, Kristie A Blum, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara A Rosenbaum, Bruce David Cheson, Nancy L Bartlett, Sumithra J Mandrekar, John P Leonard
Impact of Imaging Frequency on Progression Free Survival in Alliance Trials Enrolling Patients with Follicular Lymphoma. Blood advances (2024)
Pallawi Torka, Levi D Pederson, Michael V Knopp, David Poon, Jun Zhang, Brad S Kahl, Howard R Higley, Gary Kelloff, Jonathan W Friedberg, Lawrence H Schwartz, Wyndham H Wilson, John P Leonard, Nancy L Bartlett, Heiko Schöder, Amy S Ruppert
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis. Cancer medicine (2023)
Sanjal H Desai, Levi D Pederson, Betsy LaPlant, Raphael Mwangi, Matthew John Maurer, Jason R Young, William R Macon, Rebecca L King, Yucai Wang, James R Cerhan, Andrew L Feldman, David J Inwards, Ivana Micallef, Patrick Johnston, Luis F Porrata, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts. Blood cancer journal 12 (5) (2022)
Sarah C Rutherford, Jun Yin, Levi D Pederson, Gabriela Perez Burbano, Betsy LaPlant, Mazyar Shadman, Hongli Li, Michael L LeBlanc, Vaishalee P Kenkre, Fangxin Hong, Kristie A Blum, Travis Dockter, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara A Rosenbaum, Chaitra Ujjani, Paul M Barr, Joseph M Unger, Bruce D Cheson, Nancy L Bartlett, Brad S Kahl, Jonathan W Friedberg, Sumithra J Mandrekar, John P Leonard
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Han W Tun, Patrick B Johnston, Lisa M DeAngelis, Pamela J Atherton, Levi D Pederson, Patricia A Koenig, Craig B Reeder, Antonio M Padula Omuro, David Schiff, Brian O'Neill, Jose Pulido, Kurt A Jaeckle, Christian Grommes, Thomas E Witzig
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma. Blood 132 (21) (2018)
Ayed O Ayed, Annalisa Chiappella, Levi D Pederson, Betsy R Laplant, Angela Giovanna Congiu, Gianluca Gaidano, Michele Spina, Alessandro Re, Federica Cavallo, Gerardo Musuraca, William R Macon, Thomas Witzig, Umberto Vitolo, Grzegorz S Nowakowski
CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies. Blood cancer journal 8 (7) (2018)
A Castellino, A Chiappella, B R LaPlant, Levi D Pederson, G Gaidano, W R Macon, G Inghirami, C B Reeder, A Tucci, Rebecca L King, A Congiu, J M Foran, V Pavone, C E Rivera, M Spina, S M Ansell, F Cavallo, A L Molinari, Giovannino Ciccone, T M Habermann, T E Witzig, U Vitolo, G S Nowakowski
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials. Blood cancer journal 8 (11) (2018)
Thomas E Witzig, Patrick B Johnston, Betsy R LaPlant, Paul J Kurtin, Levi D Pederson, Dennis F Moore, Nassim H Nabbout, Daniel A Nikcevich, Kendrith M Rowland, Axel Grothey
Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU). American journal of hematology 92 (10) (2017)